ANROAlto Neuroscience Inc.
34.28USD+0.09%Mkt Cap: 1.35B $P/E: —3d ago
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients wit…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.35B $
Enterprise Value1.12B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-63.24M $
Revenue/Share—
Last Price34.28 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees68
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.43
PEG—
EV/EBITDA-12.84
EV/Revenue—
P/S—
P/B5.49
EPS (TTM)-2.32
EPS (Forward)-3.29
52W Range
3.02097% of range35.29
52W High35.29 USD
52W Low3.020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-41.84%
ROA-34.24%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-51.77M $
CapEx (TTM)24.00K $
FCF Margin—
FCF Yield-3.19%
Net Debt-220.44M $
Net Debt/EBITDA2.52
Balance Sheet
Debt/Equity0.16
Current Ratio14.85
Quick Ratio14.64
Book Value/Sh6.247 USD
Cash/Share6.211 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.38 USD
Upside (mean)+12.0%
Target Range26.00 USD – 55.00 USD
$26.00+12.0% to mean$55.00
# Analysts10
Ownership
Shares Out.39.24M
Float28.30M
Insiders4.07%
Institutions86.98%
Short Interest
Short Ratio5.8d
Short % Float9.77%
Short % Out.8.32%
Shares Short3.24M
Short (prev mo.)2.41M
Technical
SMA 5027.26 (+25.7%)
SMA 20021.07 (+62.7%)
Beta1.09
S&P 52W Chg19.18%
Avg Vol (30d)412.10K
Avg Vol (10d)502.67K
Technical Indicators
RSI (14)76.5
MACD2.0959
MACD Signal1.5638
MACD Hist.+0.5321
BB Upper34.41 USD
BB Middle29.16 USD
BB Lower23.91 USD
BB Width35.97%
ATR (14)1.986 USD
Vol Ratio (20d)0.61x